CCL2 and rheumatoid arthritis: Consistent with its anti-inflammatory properties, CBD-X treatment of collagen-induced mice reduced MCP-1 levels in the blood by twofold (Figure 3E), while showing no effect in vehicle-treated mice.Similarly, the therapeutic treatment protocol was initiated 21 days after rheumatoid arthritis onset (Supplementary Figure S3).